FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 48 filers reported holding FOGHORN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,737,610 | +42.0% | 3,147,522 | +100.0% | 1.72% | -39.7% |
| Q2 2023 | $11,079,277 | +41.7% | 1,573,761 | +24.8% | 2.85% | -58.5% |
| Q1 2023 | $7,819,818 | -2.8% | 1,261,261 | 0.0% | 6.86% | -8.9% |
| Q4 2022 | $8,046,845 | -25.6% | 1,261,261 | 0.0% | 7.53% | -25.1% |
| Q3 2022 | $10,822,000 | -36.9% | 1,261,261 | 0.0% | 10.05% | -31.1% |
| Q2 2022 | $17,153,000 | -10.7% | 1,261,261 | 0.0% | 14.59% | +30.7% |
| Q1 2022 | $19,209,000 | -33.4% | 1,261,261 | 0.0% | 11.16% | -31.9% |
| Q4 2021 | $28,845,000 | +64.2% | 1,261,261 | 0.0% | 16.40% | +92.0% |
| Q3 2021 | $17,569,000 | +30.5% | 1,261,261 | 0.0% | 8.54% | +95.5% |
| Q2 2021 | $13,458,000 | -19.0% | 1,261,261 | 0.0% | 4.37% | -21.5% |
| Q1 2021 | $16,623,000 | -35.0% | 1,261,261 | 0.0% | 5.56% | +2.8% |
| Q4 2020 | $25,566,000 | – | 1,261,261 | – | 5.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,674,120 | $63,370,600 | 4.60% |
| Euclidean Capital LLC | 3,147,522 | $15,737,610 | 1.72% |
| Birchview Capital, LP | 264,843 | $1,324,215 | 1.13% |
| Artal Group S.A. | 1,720,720 | $8,604 | 0.37% |
| Rockwood Wealth Management, LLC | 214,677 | $1,073,385 | 0.18% |
| Alphabet Inc. | 500,901 | $2,504,505 | 0.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $3,887,625 | 0.09% |
| CORNERCAP INVESTMENT COUNSEL INC | 25,819 | $129,095 | 0.02% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 343,720 | $1,718,600 | 0.02% |
| WADE G W & INC | 107,770 | $539 | 0.02% |